“…As shown in Table 1, compounds 1, 2, and 3 inhibited EBV-EA activation by 65.4, 70.1, and 64%, respectively, at a concentration of 500 mol ratio/TPA, preserving high viability of the cells. These potencies were comparable to those reported for oleanolic acid 17) and the well-known anti-tumor promoting agent EGCG 12,18) ( Table 1). Although many types of triterpenoids such as taraxastane-, multiflorane-, cucurbitane-, and oleanane-type have been reported to show an inhibitory effect on EBV-EA activation, 17,[19][20][21][22] the effect of the oleanane-type related triterpenoids, 17,[20][21][22] including compounds 1 and 2, appears to be more potent than that of the multiflorane-and cucurbitane-type tripterpenoids.…”